Main Content

NCTracks NCTracks
Search
  • Page Zoom Help
  • English,
  • Español
Navigation
  • Home
  • Providers
  • Recipients
  • Operations
Sub-navigation
  • ICD-10
  • Getting Started With NCTracks
  • Provider Communication
    • Provider Announcements - 2025
    • Provider Announcements - 2024
    • Provider Announcements - 2023
    • Provider Announcements - 2022
    • Provider Announcements - 2021
    • Provider Announcements 2020
    • Provider Announcements - 2019
    • Provider Announcements - 2018
    • Provider Announcements - 2017
    • Provider Announcements - 2016
    • Provider Announcements - 2015
    • Provider Announcements 2013-2014
    • Provider Newsletters
  • Frequently Asked Questions
  • Currently Enrolled Provider (CEP) Registration
  • Claims
  • Prior Approval
  • Provider Enrollment
  • Provider Re-credentialing/Re-verification
  • Provider Policies, Manuals, Guidelines and Forms
  • Provider User Guides & Training
  • Dental Services
  • Pharmacy Services
  • Pharmacy Claim Service Limits
  • Trading Partner Information
  • Office Administrator (OA) Change Process
  • New Medicare Card Project (formerly SSNRI)
  • June 2018 HIEA Update
You are here:
  1. Home
  2. Providers
  3. Provider Communication
  4. Provider Announcements - 2023
  5. New Medicaid Bulletin Articles Available as of May 2

New Medicaid Bulletin Articles Available as of May 2

  • May 2, 2023

The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles:

  • Patient Driven Payment Model and the Implementation of the Optional State Assessment
  • Lenacapavir Injection, for Subcutaneous Use (Sunlenca®) HCPCS Code J3490 - Unclassified Drugs: Billing Guidelines
  • Ublituximab-Xiiy Injection, for Intravenous Use (Briumvi™) HCPCS Code J3590 - Unclassified Biologics: Billing Guidelines
  • Pegfilgrastim-FpgkInjection, for Subcutaneous Use (Stimufend®) HCPCS Code J3590 - Billing Guidelines
  • Fecal Microbiota, Live - Jslm Suspension, for Rectal Use (Rebyota™) HCPCS Code J3590 - Unclassified biologics: Billing Guidelines
  • Bendamustine Hydrochloride Injection, for Intravenous Use (Baxter) HCPCS Code J9999 - Not Otherwise Classified, Antineoplastic: Billing Guidelines

Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.

    • About
    • Legal
    • Privacy
    • Accessibility
    • Contact Us
    • Site Map
    • System Requirements
    • Report Fraud
    • North Carolina Department of Health and Human Services
    • State of North Carolina
    • CSRA